Hasegawa Chihiro, Kudo Masaharu, Maruyama Haruhiko, Kimura Mikio
Department of Infectious Diseases, Nagoya City East Medical Centre, Nagoya, Japan.
Department of Pharmacy, Nagoya City East Medical Centre, Nagoya, Japan.
J Infect Chemother. 2018 Mar;24(3):216-219. doi: 10.1016/j.jiac.2017.10.008. Epub 2017 Nov 7.
Delayed haemolytic anaemia has been reported in association with intravenous artesunate treatment in patients with severe Plasmodium falciparum malaria, and furthermore, oral artemisinin-based combination therapies including artemether-lumefantrine (AL) have also been incriminated. However, definite cases of delayed haemolytic anaemia associated with AL appear to be scarce, as reported cases were often treated concomitantly with other anti-malarials. In this study, we report a severe case of delayed haemolytic anaemia following AL alone in a Japanese traveller with severe parasitaemia caused by numerous P. falciparum parasites and a few P. vivax parasites. We also stress the need by further studies to differentiate between delayed haemolytic anaemia and blackwater fever, the latter being another malaria-related haemolytic condition, more clearly than they are now.
在患有严重恶性疟原虫疟疾的患者中,已有报告称静脉注射青蒿琥酯治疗会引发迟发性溶血性贫血,此外,包括蒿甲醚-本芴醇(AL)在内的口服青蒿素联合疗法也被认为与此有关。然而,与AL相关的明确迟发性溶血性贫血病例似乎很少,因为报告的病例往往同时接受了其他抗疟药物治疗。在本研究中,我们报告了一名日本旅行者在仅接受AL治疗后发生严重迟发性溶血性贫血的病例,该旅行者因大量恶性疟原虫和少量间日疟原虫导致严重寄生虫血症。我们还强调,需要通过进一步研究比目前更清楚地区分迟发性溶血性贫血和黑水热,后者是另一种与疟疾相关的溶血性疾病。